Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R. Muraro E, et al. Among authors: turchet e. Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060. Breast Cancer Res. 2011. PMID: 22112244 Free PMC article.
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
Muraro E, Comaro E, Talamini R, Turchet E, Miolo G, Scalone S, Militello L, Lombardi D, Spazzapan S, Perin T, Massarut S, Crivellari D, Dolcetti R, Martorelli D. Muraro E, et al. Among authors: turchet e. J Transl Med. 2015 Jun 27;13:204. doi: 10.1186/s12967-015-0567-0. J Transl Med. 2015. PMID: 26116238 Free PMC article. Clinical Trial.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R. Miolo G, et al. Among authors: turchet e. BMC Cancer. 2014 Dec 15;14:954. doi: 10.1186/1471-2407-14-954. BMC Cancer. 2014. PMID: 25512030 Free PMC article. Clinical Trial.
Target therapy in elderly breast cancer patients.
Carli P, Turchet E, Quitadamo D, Spada A, Miolo G, Lamaj E, Spazzapan S, Di Lauro V, Dolcetti R, Veronesi A, Crivellari D. Carli P, et al. Among authors: turchet e. Crit Rev Oncol Hematol. 2012 Sep;83(3):422-31. doi: 10.1016/j.critrevonc.2011.12.004. Epub 2012 Jan 17. Crit Rev Oncol Hematol. 2012. PMID: 22257652 Review.
Severe asthma: One disease and multiple definitions.
Bagnasco D, Paggiaro P, Latorre M, Folli C, Testino E, Bassi A, Milanese M, Heffler E, Manfredi A, Riccio AM, De Ferrari L, Blasi F, Canevari RF, Canonica GW, Passalacqua G; SANI (Severe Asthma Network Italy); Severe Asthma Network Italy. Bagnasco D, et al. World Allergy Organ J. 2021 Nov 19;14(11):100606. doi: 10.1016/j.waojou.2021.100606. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34871335 Free PMC article.
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life.
Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). Bagnasco D, et al. World Allergy Organ J. 2021 Jan 27;14(2):100509. doi: 10.1016/j.waojou.2021.100509. eCollection 2021 Feb. World Allergy Organ J. 2021. PMID: 33598095 Free PMC article.
Gout-like arthritis following cimetidine and ranitidine.
Einarson TR, Turchet EN, Goldstein JE, MacNay KR. Einarson TR, et al. Among authors: turchet en. Drug Intell Clin Pharm. 1985 Mar;19(3):201-2. doi: 10.1177/106002808501900306. Drug Intell Clin Pharm. 1985. PMID: 3979260
Follow-up on bromocriptine-induced psychosis.
Einarson TR, Turchet EN. Einarson TR, et al. Among authors: turchet en. Clin Pharm. 1983 Nov-Dec;2(6):512. Clin Pharm. 1983. PMID: 6653055 No abstract available.
Psychotic reaction to low-dose bromocriptine.
Einarson TR, Turchet EN. Einarson TR, et al. Among authors: turchet en. Clin Pharm. 1983 May-Jun;2(3):273-4. Clin Pharm. 1983. PMID: 6883957 No abstract available.